← Leaderboards
James F Chmiel
Indiana University Indianapolis
$2,201,427
Attributed
$2,201,427
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $518.8K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,201,427 · 1
By mechanism
P01$2,201,427 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Benjamin M Gaston$23,153,633
- James Croop$249,463
- Rohit Loomba$20,349,897
- Weinian Shou$9,664,112
- Sebastien Laulhe$1,548,409
Others in their field
Other Emerging Leaders on “Cost Effective”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- John Damon Chodera · Sloan-Kettering Inst Can Research$36,078,498
- Karen Martier · Westat, Inc.$35,207,008
- Gary Fanger · Rise Therapeutics, Llc$21,006,928
- Chani Eduard · Precision Bioservices, Inc.$19,909,203
Research focus
Cost EffectiveAdverse EventAgreementAsthmaBasic ScienceArchivesAreaBiologicalBiological ProcessBiopsyBiostatistics CoreBudgetsCareerClinical DataClinical InvestigationClinical ResearchClinical TrialsClinical Trials Data Monitoring CommitteesCollectionCommunicationConduct Clinical TrialsConsultationsContractsData Analyses
Grant awards (5)
Severe Asthma Clinical Studies Core$518,769
P01 · FY2025 · HL · contact PI
Severe Asthma Clinical Studies Core$469,806
P01 · FY2024 · HL · contact PI
Severe Asthma Clinical Studies Core$471,027
P01 · FY2023 · HL · contact PI
Severe Asthma Clinical Studies Core$439,236
P01 · FY2022 · HL · contact PI
Severe Asthma Clinical Studies Core$302,589
P01 · FY2021 · HL · contact PI